Stocktoria
Fulcrum Therapeutics, Inc. FULC
Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2019-07-18
Fulcrum Therapeutics, Inc. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| BlackRock Finance, Inc. | 4,798,522 | $29.8M | 7.21% |
| Point72 Asset Management, L.P. | 2,074,855 | $15.9M | 3.12% |
| D. E. Shaw & Co., Inc. | 1,623,281 | $12.5M | 2.44% |
| CITADEL ADVISORS LLC | 1,350,686 | $10.4M | 2.03% |
| AQR CAPITAL MANAGEMENT LLC | 543,165 | $4.2M | 0.82% |
| MILLENNIUM MANAGEMENT LLC | 356,471 | $2.7M | 0.54% |
| TWO SIGMA INVESTMENTS, LP | 139,000 | $1.1M | 0.21% |
| RENAISSANCE TECHNOLOGIES LLC | 13,600 | $104,312 | 0.02% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.